Association of Liver Fibrosis Markers with Mortality Outcomes in Patients with Chronic Kidney Disease and Coronary Artery Disease: Insights from the NHANES 1999-2018 Data [0.03%]
肝纤维化标志物与慢性肾脏病和冠状动脉疾病患者死亡风险的关系：来自NHANES 1999-2018数据的启示
Zixiang Ye,Enmin Xie,Ziyu Guo et al.
Zixiang Ye et al.
Introduction: The objective of this research is to explore the possible link between markers of liver fibrosis and survival rates in a group of adults who have been diagnosed with both chronic kidney disease (CKD) and cor...
EMCREG-International Multidisciplinary Consensus Panel on Management of Hyperkalemia in Chronic Kidney Disease (CKD) and Heart Failure [0.03%]
EMCREG慢性肾脏病（CKD）和心力衰竭高钾血症管理国际多学科共识小组
Natalie Kreitzer,Nancy M Albert,Alpesh N Amin et al.
Natalie Kreitzer et al.
Background: Hyperkalemia, generally defined as serum potassium levels greater than 5.0 mEq/L, poses significant clinical risks, including cardiac toxicity and muscle weakness. Its prevalence and severity increase in patie...
Cardiorenal disease and heart failure with preserved ejection fraction: Two sides of the same coin [0.03%]
心肾疾病和射血分数保留型心力衰竭：一枚硬币的两面
Gonzalo Núñez-Marína,Enrique Santas
Gonzalo Núñez-Marína
Background: Heart failure with preserved ejection fraction (HFpEF) and chronic kidney disease (CKD) have a strong pathophysiological interrelationship, and their combination worsens prognosis. ...
Predicting In-Hospital Mortality in Patients With End-Stage Renal Disease Receiving Extracorporeal Membrane Oxygenation Therapy [0.03%]
血液净化治疗终末期肾病患者的院内死亡预测模型
Tsung-Yu Tsai,Pei-Chun Fan,Cheng-Chia Lee et al.
Tsung-Yu Tsai et al.
Introduction: Patients on extracorporeal membrane oxygenation (ECMO) often experience worse renal outcomes and higher mortality rates as the severity of kidney injury increases. Nevertheless, the in-hospital mortality ris...
Changes in Antigen Carbohydrate 125 in Patients Receiving Dapagliflozin Following an Admission for Acute Heart Failure [0.03%]
达格列净治疗急性心力衰竭患者后抗原糖类125的变化趋势分析
Gema Miñana,Rafael de la Espriella,Miguel Lorenzo-Hernández et al.
Gema Miñana et al.
Introduction: Antigen carbohydrate 125 (CA125) has emerged as a proxy of fluid overload and inflammation in acute heart failure (AHF). We aimed to evaluate the influence of dapagliflozin on CA125 levels within the first w...
Cardiorenal syndrome in Heart Failure with Preserved Ejection Fraction: Insights into pathophysiology and recent advances [0.03%]
射血分数保留的心力衰竭中的心肾综合征：病理生理学见解和最新进展
Harshwardhan Khandait,Sohail Singh Sodhi,Ninad Khandekar et al.
Harshwardhan Khandait et al.
Background Cardiorenal syndrome (CRS) refers to the bidirectional interactions between the acutely or chronically dysfunctioning heart and kidney that lead to poor outcomes. Due to the evolving literature on renal impairment and heart failu...
Cardiovascular and Kidney Outcomes of Glucagon-Like Peptide 1 Receptor Agonist Therapy in Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis [0.03%]
胰高血糖素样肽-1受体激动剂治疗2型糖尿病和慢性肾脏病患者心血管和肾脏结局的系统评价和meta分析
Nicole Felix,Mateus de Miranda Gauza,Vinicius Bittar et al.
Nicole Felix et al.
Introduction: The effects of glucagon-like receptor 1 receptor agonists (GLP-1 RA) in patients with diabetes and established chronic kidney disease (CKD) remain unclear. ...
The role of Wnt3a/β-catenin/TCF7L2 pathway in diabetes and cardiorenal complications [0.03%]
Wnt3a/β-catenin/TCF7L2信号通路在糖尿病及其心肾并发症中的作用
Yilinuer Adeerjiang,Abudulimu Sidike,Xiao-Xue Gan et al.
Yilinuer Adeerjiang et al.
Background: Diabetes mellitus (DM) is a prevalent chronic disease that is becoming increasingly common worldwide and can lead to a number of dangerous complications. The Wnt signaling pathway is important for the onset an...
Association between arterial stiffness, carbamylation, and mortality in patients undergoing coronary angiography with no or mild chronic kidney disease [0.03%]
动脉僵硬度、碳酰化与冠状动脉造影患者无慢性肾脏病的关联性研究
Clara Daschner,Marcus E Kleber,Ksenija Stach et al.
Clara Daschner et al.
Introduction: The processes of atherosclerosis, inflammation, and carbamylation are closely linked in cardiovascular (CV) disease, but the potential of carbamylation burden as a CV mortality predictor is unclear, especial...
Inflammation and Arterial Stiffness as Drivers of Cardiovascular Risk in Kidney Disease [0.03%]
肾脏疾病中炎症和动脉僵硬度的心血管风险驱动因素分析
Lorenzo Lo Cicero,Paolo Lentini,Concetto Sessa et al.
Lorenzo Lo Cicero et al.
Background: Patients with chronic kidney disease (CKD) have an increased cardiovascular (CV) risk. The lower the glomerular filtration rate, the higher the CV risk. ...